Developer docs
API playgroundTry for free, no card

Search company profiles

Paperplane Therapeutics

Full company profile

uuid0002x5b

Namestring
Paperplane Therapeutics
Legal namestring
Paperplane Therapeutics Inc.
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Paperplane Therapeutics is a Canadian health technology company founded in 2019 in Granby, Quebec, that develops prescription-use virtual reality therapies for managing pediatric pain and anxiety during medical and dental procedures. The company's core platform is built on cognitive-behavioral therapy methods delivered through immersive VR experiences, with proprietary Headstill Technology™ that uses visual feedback (screen darkening) to maintain patient stillness during procedures. Its product portfolio includes DREAM (Health Canada approved for needle procedures, vaccinations, dressing changes, suturing), INSPIRE (sensor-guided deep breathing therapy with real-time monitoring), IMAGINE (interactive MRI preparation simulation with patient movement scoring), and a dental-focused VR solution featuring Action, Puzzle, and Calm experience categories.

The company operates a dual go-to-market model. For healthcare facilities, it sells enterprise licenses combining software, clinical-grade hardware (headsets, controllers, tablets), fleet management, onboarding, training, and ongoing support, with pricing tailored per facility. For dental practices, it offers a self-serve e-commerce product at $995 USD upfront plus $99 USD/month subscription (volume pricing of $49/month per additional kit), with a 60-day money-back guarantee and a distribution partnership with Benco Dental. Strategic customers and validation partners include Mayo Clinic, Cedars-Sinai Accelerator Cohort #9, CHU Sainte-Justine (first hospital deployment), CHEO, Boston Children's Hospital, Shriners Children's Hospital, and University of Michigan Health-Sparrow, with clinical trial programs spanning orthopedics, neonatology, dentistry, burn care, and pediatric neuroradiology.

The company is venture-backed, having raised $1.5M in February 2025 led by Glen Ventures with participation from Anges Quebec, Aventure Capital, Cedars-Sinai, Investissement Quebec, and Center of Aging and Brain Health Innovation, alongside prior accelerator funding from Creative Destruction Lab and Centech. Revenue is generated through subscription/recurring licensing plus hardware sales; the company has also received regulatory milestones including Health Canada approval for DREAM and EU MDR 2017/745 compliance classification. Operational outcomes demonstrated in pilots include a 90% success rate for MRI procedures without anesthesia at CHEO (reducing wait times from 550 days to under a week), ~$2,600 per-patient cost savings from avoided anesthesia, and 50,000+ patients treated during the Quebec COVID-19 vaccination campaign.

Short descriptiontext

Paperplane Therapeutics is a Canadian health-tech company developing Health Canada-approved virtual reality therapies (DREAM, INSPIRE, IMAGINE) for managing pediatric pain and anxiety during medical and dental procedures, with enterprise licensing for hospitals and self-serve subscriptions for dental practices.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersGranby, Canada
HQ citystring
Granby
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
virtual reality therapy, pediatric pain management, dental anxiety software, medical VR therapeutics, clinical VR platform
Industry2 codes
PRIMARYHLACANAL
Pediatrics & Adolescent Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAH
Therapeutic Companion Apps (Drug-Device-Digital Combination)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code1 code
  • Dental Equipment and Supplies Manufacturing339114
SIC code3 codes
  • Services-Prepackaged Software7372
  • Surgical & Medical Instruments & Apparatus3841
  • Dental Equipment & Supplies3843
Product category
Virtual Reality Therapeutics Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Healthcare Licensing Model
TypeSubscription Recurring
Description

Comprehensive license model for hospitals, clinics, and care facilities, tailor-made to specific needs. Includes software, hardware package (headset, controllers, tablet), fleet management, remote updates, warranty, onboarding, training, and ongoing technical support.

paperplanetherapeutics.com
2Dental Practice Subscriptions
TypeSubscription Recurring
Description

Subscription-based model for dental practices with initial kit purchase ($995 USD) plus monthly subscription ($99 USD/month). Volume pricing available for additional kits at $49 USD/month per kit. Includes fully managed software with remote updates.

paperplanetherapeutics.com
3Hardware Sales
TypeHardware Sales
Description

Direct hardware sales including VR/AR headsets, controllers, compute units, cables, chargers, protective materials, and cases. Hardware is designed for clinical use with medical-grade materials for easy cleaning and sterilization.

paperplanetherapeutics.com
Marketing channels12 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations, Infrastructure
Pricing details3 tiers
1Dental Starter Kit - First Unit
ModelHybridBilling cadenceMonthly
Notes

$995 USD upfront + $99 USD/month subscription. Includes AR glasses, cables, chargers, compute unit (battery), controller, protective materials, cases, onboarding materials, warranty coverage, and rapid replacement.

paperplanetherapeutics.com
2Dental Additional Kits - Volume Pricing
ModelHybridBilling cadenceMonthly
Notes

$995 USD upfront per kit + $49 USD/month per additional kit (for practices purchasing additional units beyond the first). Contact sales for enterprise volume pricing.

paperplanetherapeutics.com
3Healthcare/Hospital License
ModelSubscriptionBilling cadenceAnnual
Notes

Comprehensive license model including software, hardware (headset, controllers, tablet), fleet management, remote updates, warranty, full onboarding, training, and ongoing technical support. Pricing tailored to specific facility needs.

paperplanetherapeutics.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1DREAM
Description

Immersive virtual reality therapy designed to assist children during medical procedures, managing pain and anxiety. Clinically validated and Health Canada approved. Helped more than 50,000 patients during the COVID vaccination campaign.

paperplanetherapeutics.com
+3 more records
Core offering1 text field

Paperplane Therapeutics designs and sells clinically validated virtual reality software therapies that distract and calm pediatric and adult patients during medical and dental procedures. Its portfolio includes DREAM (Health Canada approved VR distraction during procedures such as vaccinations and suturing), INSPIRE (sensor-guided breathing therapy), IMAGINE (MRI preparation simulation), and a Dentalcare/Stress Gone solution using Headstill Technology™. Offerings are sold as turnkey packages combining proprietary software, clinical-grade VR/AR hardware, fleet management, onboarding, and ongoing technical support, delivered via hospital licensing and a direct subscription model for dental practices.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • MRI wait times reduced from 550 days to under a week
+9 more records
Product overview1 text field

Paperplane Therapeutics offers a portfolio of immersive virtual reality therapies for pain and anxiety management in healthcare settings. The core products include DREAM (VR therapy for children during medical procedures), INSPIRE (breathing-guided VR therapy with real-time monitoring), and IMAGINE (MRI preparation simulation). For dental care, the company offers a complete VR solution featuring Headstill Technology that keeps patients still during procedures through three experience categories: Action, Puzzle, and Calm. The company provides turnkey solutions combining software (tailored modular therapies), hardware (headsets, controllers, tablets with fleet management), and implementation services (onboarding, training, ongoing support). All products are designed for clinical use with evidence-based, non-pharmacological approaches and are supported by clinical trials and partnerships with healthcare institutions.

Product and service4 records
1DREAM VR Therapy
CategoryHealthcare VR Therapy Software
Description

An immersive virtual reality therapy that helps children manage pain and distress during medical procedures such as vaccinations, dressing changes, venipunctures, intraosseous pin removals, suturing, and fracture reductions. It is clinically validated, Health Canada approved, and based on cognitive-behavioral therapy methods; intended for hospitals, clinics, and care facilities treating pediatric patients.

2INSPIRE VR Therapy
CategoryHealthcare VR Therapy Software
Description

A virtual reality therapy that uses a sensor-guided deep-breathing technique to engage the parasympathetic nervous system and induce relaxation during painful or stressful medical procedures. Real-time monitoring of patient breathing via an advanced sensor and analytics delivers biofeedback to clinicians; targets pain, anxiety, and isolation for patients in clinical settings.

3IMAGINE VR Therapy
CategoryHealthcare VR Therapy Software
Description

An interactive VR simulation designed to prepare children for MRI scans, with a preparation phase and an MRI simulation phase that uses audiovisual cues replicating the actual procedure. Clinicians can use the patient's movement score inside the simulation to predict the child's readiness for the real MRI scan, helping reduce or eliminate the need for anesthesia.

4Paperplane VR Dentalcare Solution (Stress Gone)
CategoryDental VR Therapy Software
Description

A turnkey VR dental anxiety solution for dental practices that combines AR/VR headset hardware, compute unit, controllers, onboarding materials, warranty, and a managed software subscription. The clinical software includes three experience categories — Action (interactive games), Puzzle (cognitive games), and Calm (relaxation/mindfulness) — designed to keep patients engaged and still during dental procedures via Headstill Technology™. Sold direct online at $995 USD per starter kit plus $99 USD/month per kit, with volume pricing at $49 USD/month for additional kits.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership20 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborating on VR project to reduce need for general anesthesia in children undergoing MRI. Chief of Pediatric Neuroradiology Dr. V. Michelle Silvera leading the initiative. Aligns with Mayo Clinic's focus on minimizing sedation in pediatric neuroradiology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Selected for 9th cohort of Cedars-Sinai Accelerator program providing mentorship, resources, and access to Cedars-Sinai hospital network for clinical trials and product validation across various departments.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

First hospital to implement Paperplane's VR technology. Ongoing partnership conducting clinical trials in orthopedics, neonatology, dentistry, and burn care. Research projects include VR-TOOTH, DEVINCI, PINS, MOBILE, and IMAGINE studies.

4CHEO
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CHEO is using Paperplane's VR technology to make MRIs easier for children. Partnership resulted in dramatic wait time reduction from 550 days to under a week. 90% success rate without anesthesia in 36-patient pilot study presented at RSNA 2024.

paperplanetherapeutics.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner in IMAGINE project to validate effectiveness of VR in managing pre-procedural anxiety in children undergoing MRI scans.

6Montreal Shriners Hospital for Children
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner in PINS multicenter clinical study measuring therapeutic effect of VR compared to tablet for pain and anxiety management in children during painful outpatient procedures.

paperplanetherapeutics.com
7Montreal Children's Hospital (MUHC)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner in PINS multicenter clinical study measuring therapeutic effect of VR compared to tablet for pain and anxiety management in children during painful outpatient procedures.

paperplanetherapeutics.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-founder Prof. David Paquin's academic institution. Full professor in Creation and New Media Department with 20 years experience in VR/game design research.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partner where founders David Paquin, Jean-Simon Fortin, and Sylvie Le May presented research as part of Jeu ET Intelligence Numérique series organized by inven_T, Center D'Innovation Technosociale U de M.

10Polytechnique Montréal
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partner institution listed on About page.

paperplanetherapeutics.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partner institution listed on About page.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Listed as Healthtech Start-Ups to Watch 2021; Canadian research hub for medical technologies supporting innovation in healthcare.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Dental-specific distribution partner for Paperplane's dental VR solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Accelerator program supporting science-based companies with mentorship and resources for scaling.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Technology accelerator in Montreal supporting innovative health tech companies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Healthcare partner organization listed on About page.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Healthcare partner organization listed on About page.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborative mental health project between Paperplane Therapeutics and Telus; featured in La Presse coverage.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partner organization listed on About page.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner organization from Minnesota's healthcare and medical technology ecosystem.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AppliedVR is an FDA-authorized VR therapeutics company (EaseVRx) for chronic lower-back pain and procedural anxiety, with published clinical evidence and CPT code coverage. Comparable to Paperplane as a leading VR-DTx company pursuing payer/provider adoption through clinical validation and reimbursement pathways.

TypeBroad incumbent
Description

Penumbra's REAL Immersive System is a commercial VR rehabilitation platform used in hospitals and clinics for stroke and neuro-recovery. Comparable to Paperplane as a clinically validated, hospital-deployed VR therapy solution targeting specific patient populations.

3Psious
TypeEmerging player
Description

Psious provides VR-based exposure therapy for anxiety disorders, phobias, and PTSD used by mental-health clinicians. Comparable to Paperplane for VR-driven anxiety treatment with a clinical-deployment model, though focused on mental-health clinicians rather than pediatric procedures.

TypeBroad incumbent
Description

MindMaze is a neuro-rehabilitation and digital therapeutics company offering VR-based platforms for cognitive and motor recovery in hospital and clinic settings. Comparable to Paperplane for hospital-grade VR therapeutic products with regulatory clearances and clinical evidence.

TypeDirect peer
Description

Smileyscope is a pediatric-focused VR therapeutics company providing procedural-distraction and pain-management VR for children during needles, IVs, and dental procedures. Highly comparable to Paperplane Therapeutics given shared pediatric procedural anxiety use case and similar clinical-validated product positioning.

6XRHealth
TypeDirect peer
Description

XRHealth operates a VR-based telehealth platform for pain, anxiety, stroke rehab, and physical therapy, combining headset delivery with clinician-supervised remote sessions. Comparable to Paperplane for VR-as-therapeutic delivery model, although it is more adult and rehabilitation-focused.

TypeDirect peer
Description

BehaVR develops VR-based digital therapeutics for chronic pain, anxiety, and mental health conditions, with clinical trials and pharma partnerships. Comparable to Paperplane for evidence-based VR therapeutics targeting pain and anxiety indications.

TypeBroad incumbent
Description

Headspace Health delivers evidence-based digital mental health interventions (now combined with Ginger) to employers, payers, and providers for anxiety and stress. Comparable to Paperplane for evidence-backed digital therapeutics targeting anxiety, though via app-based delivery rather than immersive VR.

9Calm Health
TypeBroad incumbent
Description

Calm Health extends the consumer Calm platform into payer- and provider-distributed mental health programs including anxiety and pain management. Comparable to Paperplane as a digital therapeutic for anxiety with provider/payer distribution, though delivered via mobile rather than immersive VR.

TypeEmerging player
Description

Limbic is a UK-based digital therapeutics company with CE-marked AI-driven cognitive behavioral therapy products for anxiety and depression, distributed via NHS and other providers. Comparable to Paperplane as a regulated, evidence-based DTx for anxiety targeting provider and payer adoption.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Paperplane Therapeutics

Virtual Reality Therapeutics Softwarepaperplanetherapeutics.com

Paperplane Therapeutics is a Canadian health-tech company developing Health Canada-approved virtual reality therapies (DREAM, INSPIRE, IMAGINE) for managing pediatric pain and anxiety during medical and dental procedures, with enterprise licensing for hospitals and self-serve subscriptions for dental practices.

What Paperplane Therapeutics does

Paperplane Therapeutics is a Canadian health technology company founded in 2019 in Granby, Quebec, that develops prescription-use virtual reality therapies for managing pediatric pain and anxiety during medical and dental procedures. The company's core platform is built on cognitive-behavioral therapy methods delivered through immersive VR experiences, with proprietary Headstill Technology™ that uses visual feedback (screen darkening) to maintain patient stillness during procedures. Its product portfolio includes DREAM (Health Canada approved for needle procedures, vaccinations, dressing changes, suturing), INSPIRE (sensor-guided deep breathing therapy with real-time monitoring), IMAGINE (interactive MRI preparation simulation with patient movement scoring), and a dental-focused VR solution featuring Action, Puzzle, and Calm experience categories.

The company operates a dual go-to-market model. For healthcare facilities, it sells enterprise licenses combining software, clinical-grade hardware (headsets, controllers, tablets), fleet management, onboarding, training, and ongoing support, with pricing tailored per facility. For dental practices, it offers a self-serve e-commerce product at $995 USD upfront plus $99 USD/month subscription (volume pricing of $49/month per additional kit), with a 60-day money-back guarantee and a distribution partnership with Benco Dental. Strategic customers and validation partners include Mayo Clinic, Cedars-Sinai Accelerator Cohort #9, CHU Sainte-Justine (first hospital deployment), CHEO, Boston Children's Hospital, Shriners Children's Hospital, and University of Michigan Health-Sparrow, with clinical trial programs spanning orthopedics, neonatology, dentistry, burn care, and pediatric neuroradiology.

The company is venture-backed, having raised $1.5M in February 2025 led by Glen Ventures with participation from Anges Quebec, Aventure Capital, Cedars-Sinai, Investissement Quebec, and Center of Aging and Brain Health Innovation, alongside prior accelerator funding from Creative Destruction Lab and Centech. Revenue is generated through subscription/recurring licensing plus hardware sales; the company has also received regulatory milestones including Health Canada approval for DREAM and EU MDR 2017/745 compliance classification. Operational outcomes demonstrated in pilots include a 90% success rate for MRI procedures without anesthesia at CHEO (reducing wait times from 550 days to under a week), ~$2,600 per-patient cost savings from avoided anesthesia, and 50,000+ patients treated during the Quebec COVID-19 vaccination campaign.

Paperplane Therapeutics firmographics

Firmographics
Name
Paperplane Therapeutics
Legal name
Paperplane Therapeutics Inc.
Website
https://paperplanetherapeutics.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
Paperplane Therapeutics is a Canadian health-tech company developing Health Canada-approved virtual reality therapies (DREAM, INSPIRE, IMAGINE) for managing pediatric pain and anxiety during medical and dental procedures, with enterprise licensing for hospitals and self-serve subscriptions for dental practices.
Ownership category
akta.pro rank

Paperplane Therapeutics industry classification

Industry
Product category
Virtual Reality Therapeutics Software
NAICS
Dental Equipment and Supplies Manufacturing (339114)
SIC
Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841), Dental Equipment & Supplies (3843)
akta.pro industry
PRIMARYHLACANAL
Pediatrics & Adolescent Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAH
Therapeutic Companion Apps (Drug-Device-Digital Combination)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Virtual reality therapy
  • Pediatric pain management
  • Dental anxiety software
  • Medical VR therapeutics
  • Clinical VR platform

Where Paperplane Therapeutics is headquartered

Location

Headquarters

HQ city
Granby
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

Paperplane Therapeutics business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations, Infrastructure

Revenue model

  1. Healthcare Licensing Model: Comprehensive license model for hospitals, clinics, and care facilities, tailor-made to specific needs. Includes software, hardware package (headset, controllers, tablet), fleet management, remote updates, warranty, onboarding, training, and ongoing technical support.
  2. Dental Practice Subscriptions: Subscription-based model for dental practices with initial kit purchase ($995 USD) plus monthly subscription ($99 USD/month). Volume pricing available for additional kits at $49 USD/month per kit. Includes fully managed software with remote updates.
  3. Hardware Sales: Direct hardware sales including VR/AR headsets, controllers, compute units, cables, chargers, protective materials, and cases. Hardware is designed for clinical use with medical-grade materials for easy cleaning and sterilization.

Pricing tiers

ModelBillingPrice
HybridMonthlyDental Starter Kit - First Unit
HybridMonthlyDental Additional Kits - Volume Pricing
SubscriptionAnnualHealthcare/Hospital License

Go-to-market motion1 record

Distribution channels4 records

Marketing channels12 records

Paperplane Therapeutics product offering

Product offering

Core offering

Paperplane Therapeutics designs and sells clinically validated virtual reality software therapies that distract and calm pediatric and adult patients during medical and dental procedures. Its portfolio includes DREAM (Health Canada approved VR distraction during procedures such as vaccinations and suturing), INSPIRE (sensor-guided breathing therapy), IMAGINE (MRI preparation simulation), and a Dentalcare/Stress Gone solution using Headstill Technology™. Offerings are sold as turnkey packages combining proprietary software, clinical-grade VR/AR hardware, fleet management, onboarding, and ongoing technical support, delivered via hospital licensing and a direct subscription model for dental practices.

Product overview

Paperplane Therapeutics offers a portfolio of immersive virtual reality therapies for pain and anxiety management in healthcare settings. The core products include DREAM (VR therapy for children during medical procedures), INSPIRE (breathing-guided VR therapy with real-time monitoring), and IMAGINE (MRI preparation simulation). For dental care, the company offers a complete VR solution featuring Headstill Technology that keeps patients still during procedures through three experience categories: Action, Puzzle, and Calm. The company provides turnkey solutions combining software (tailored modular therapies), hardware (headsets, controllers, tablets with fleet management), and implementation services (onboarding, training, ongoing support). All products are designed for clinical use with evidence-based, non-pharmacological approaches and are supported by clinical trials and partnerships with healthcare institutions.

Differentiator

Problem solved

Functional benefit

Brands

  • DREAM: Immersive virtual reality therapy designed to assist children during medical procedures, managing pain and anxiety. Clinically validated and Health Canada approved. Helped more than 50,000 patients during the COVID vaccination campaign.
  • INSPIRE
  • IMAGINE
  • Headstill Technology™

Products and services

  • DREAM VR Therapy An immersive virtual reality therapy that helps children manage pain and distress during medical procedures such as vaccinations, dressing changes, venipunctures, intraosseous pin removals, suturing, and fracture reductions. It is clinically validated, Health Canada approved, and based on cognitive-behavioral therapy methods; intended for hospitals, clinics, and care facilities treating pediatric patients.
  • INSPIRE VR Therapy A virtual reality therapy that uses a sensor-guided deep-breathing technique to engage the parasympathetic nervous system and induce relaxation during painful or stressful medical procedures. Real-time monitoring of patient breathing via an advanced sensor and analytics delivers biofeedback to clinicians; targets pain, anxiety, and isolation for patients in clinical settings.
  • IMAGINE VR Therapy An interactive VR simulation designed to prepare children for MRI scans, with a preparation phase and an MRI simulation phase that uses audiovisual cues replicating the actual procedure. Clinicians can use the patient's movement score inside the simulation to predict the child's readiness for the real MRI scan, helping reduce or eliminate the need for anesthesia.
  • Paperplane VR Dentalcare Solution (Stress Gone) A turnkey VR dental anxiety solution for dental practices that combines AR/VR headset hardware, compute unit, controllers, onboarding materials, warranty, and a managed software subscription. The clinical software includes three experience categories — Action (interactive games), Puzzle (cognitive games), and Calm (relaxation/mindfulness) — designed to keep patients engaged and still during dental procedures via Headstill Technology™. Sold direct online at $995 USD per starter kit plus $99 USD/month per kit, with volume pricing at $49 USD/month for additional kits.

Quantifiable outcome

  • MRI wait times reduced from 550 days to under a week
  • +9 more outcomes

Companies that use Paperplane Therapeutics

Customer profile

Named customers12 records

Segments3 records

Ideal customer profiles2 records

Paperplane Therapeutics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature5 records

Paperplane Therapeutics partnerships and signals

Strategic signal

Partnerships

20 partnerships are on record, tiered core and minor.

  • Mayo CliniccoreStrategic or Co-development PartnerCollaborating on VR project to reduce need for general anesthesia in children undergoing MRI. Chief of Pediatric Neuroradiology Dr. V. Michelle Silvera leading the initiative. Aligns with Mayo Clinic's focus on minimizing sedation in pediatric neuroradiology.
  • Cedars-Sinai AcceleratorcoreStrategic or Co-development PartnerSelected for 9th cohort of Cedars-Sinai Accelerator program providing mentorship, resources, and access to Cedars-Sinai hospital network for clinical trials and product validation across various departments.
  • CHU Sainte-JustinecoreStrategic or Co-development PartnerFirst hospital to implement Paperplane's VR technology. Ongoing partnership conducting clinical trials in orthopedics, neonatology, dentistry, and burn care. Research projects include VR-TOOTH, DEVINCI, PINS, MOBILE, and IMAGINE studies.
  • CHEOcoreStrategic or Co-development PartnerCHEO is using Paperplane's VR technology to make MRIs easier for children. Partnership resulted in dramatic wait time reduction from 550 days to under a week. 90% success rate without anesthesia in 36-patient pilot study presented at RSNA 2024.
  • Hôpital Maisonneuve-RosemontcoreStrategic or Co-development PartnerPartner in IMAGINE project to validate effectiveness of VR in managing pre-procedural anxiety in children undergoing MRI scans.
  • Montreal Shriners Hospital for ChildrencoreStrategic or Co-development PartnerPartner in PINS multicenter clinical study measuring therapeutic effect of VR compared to tablet for pain and anxiety management in children during painful outpatient procedures.
  • Montreal Children's Hospital (MUHC)coreStrategic or Co-development PartnerPartner in PINS multicenter clinical study measuring therapeutic effect of VR compared to tablet for pain and anxiety management in children during painful outpatient procedures.
  • Université du Québec en Abitibi-Témiscamingue (UQAT)coreStrategic or Co-development PartnerCo-founder Prof. David Paquin's academic institution. Full professor in Creation and New Media Department with 20 years experience in VR/game design research.
  • Université de MontréalminorStrategic or Co-development PartnerAcademic partner where founders David Paquin, Jean-Simon Fortin, and Sylvie Le May presented research as part of Jeu ET Intelligence Numérique series organized by inven_T, Center D'Innovation Technosociale U de M.
  • Polytechnique MontréalminorStrategic or Co-development PartnerAcademic partner institution listed on About page.
  • HEC MontréalminorStrategic or Co-development PartnerAcademic partner institution listed on About page.
  • Medteq+coreStrategic or Co-development PartnerListed as Healthtech Start-Ups to Watch 2021; Canadian research hub for medical technologies supporting innovation in healthcare.
  • Benco DentalcoreChannel Partner/ Reseller/ DistributorDental-specific distribution partner for Paperplane's dental VR solutions.
  • Creative Destruction Lab (CDL)coreStrategic or Co-development PartnerAccelerator program supporting science-based companies with mentorship and resources for scaling.
  • CentechcoreStrategic or Co-development PartnerTechnology accelerator in Montreal supporting innovative health tech companies.
  • Boston Children's HospitalcoreStrategic or Co-development PartnerHealthcare partner organization listed on About page.
  • University of Michigan Health-SparrowcoreStrategic or Co-development PartnerHealthcare partner organization listed on About page.
  • TelusminorStrategic or Co-development PartnerCollaborative mental health project between Paperplane Therapeutics and Telus; featured in La Presse coverage.
  • AllureminorStrategic or Co-development PartnerStrategic partner organization listed on About page.
  • Medical AlleyminorStrategic or Co-development PartnerPartner organization from Minnesota's healthcare and medical technology ecosystem.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Paperplane Therapeutics competitors and assessment

Company assessment

Direct peers

  • AppliedVR: AppliedVR is an FDA-authorized VR therapeutics company (EaseVRx) for chronic lower-back pain and procedural anxiety, with published clinical evidence and CPT code coverage. Comparable to Paperplane as a leading VR-DTx company pursuing payer/provider adoption through clinical validation and reimbursement pathways.
  • Smileyscope: Smileyscope is a pediatric-focused VR therapeutics company providing procedural-distraction and pain-management VR for children during needles, IVs, and dental procedures. Highly comparable to Paperplane Therapeutics given shared pediatric procedural anxiety use case and similar clinical-validated product positioning.
  • XRHealth: XRHealth operates a VR-based telehealth platform for pain, anxiety, stroke rehab, and physical therapy, combining headset delivery with clinician-supervised remote sessions. Comparable to Paperplane for VR-as-therapeutic delivery model, although it is more adult and rehabilitation-focused.
  • BehaVR: BehaVR develops VR-based digital therapeutics for chronic pain, anxiety, and mental health conditions, with clinical trials and pharma partnerships. Comparable to Paperplane for evidence-based VR therapeutics targeting pain and anxiety indications.

Broad incumbents

  • Penumbra (REAL Immersive System): Penumbra's REAL Immersive System is a commercial VR rehabilitation platform used in hospitals and clinics for stroke and neuro-recovery. Comparable to Paperplane as a clinically validated, hospital-deployed VR therapy solution targeting specific patient populations.
  • MindMaze: MindMaze is a neuro-rehabilitation and digital therapeutics company offering VR-based platforms for cognitive and motor recovery in hospital and clinic settings. Comparable to Paperplane for hospital-grade VR therapeutic products with regulatory clearances and clinical evidence.
  • Headspace Health: Headspace Health delivers evidence-based digital mental health interventions (now combined with Ginger) to employers, payers, and providers for anxiety and stress. Comparable to Paperplane for evidence-backed digital therapeutics targeting anxiety, though via app-based delivery rather than immersive VR.
  • Calm Health: Calm Health extends the consumer Calm platform into payer- and provider-distributed mental health programs including anxiety and pain management. Comparable to Paperplane as a digital therapeutic for anxiety with provider/payer distribution, though delivered via mobile rather than immersive VR.

Emerging players

  • Psious: Psious provides VR-based exposure therapy for anxiety disorders, phobias, and PTSD used by mental-health clinicians. Comparable to Paperplane for VR-driven anxiety treatment with a clinical-deployment model, though focused on mental-health clinicians rather than pediatric procedures.
  • Limbic (previously Headspace for Health / mental-health DTx): Limbic is a UK-based digital therapeutics company with CE-marked AI-driven cognitive behavioral therapy products for anxiety and depression, distributed via NHS and other providers. Comparable to Paperplane as a regulated, evidence-based DTx for anxiety targeting provider and payer adoption.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Paperplane Therapeutics social profiles

Digital presence

Paperplane Therapeutics compliance and trust

Trust signal

Compliance3 records

Paperplane Therapeutics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Paperplane Therapeutics leadership team

Management profile

Number of profiles

Profiles12 records

Paperplane Therapeutics funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Paperplane Therapeutics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Paperplane Therapeutics

What does Paperplane Therapeutics do?

Paperplane Therapeutics designs and sells clinically validated virtual reality software therapies that distract and calm pediatric and adult patients during medical and dental procedures. Its portfolio includes DREAM (Health Canada approved VR distraction during procedures such as vaccinations and suturing), INSPIRE (sensor-guided breathing therapy), IMAGINE (MRI preparation simulation), and a Dentalcare/Stress Gone solution using Headstill Technology™. Offerings are sold as turnkey packages combining proprietary software, clinical-grade VR/AR hardware, fleet management, onboarding, and ongoing technical support, delivered via hospital licensing and a direct subscription model for dental practices.

Is Paperplane Therapeutics a public or private company?

Paperplane Therapeutics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Paperplane Therapeutics founded?

Paperplane Therapeutics was founded in 2019. It employs 1 to 10 people.

Where is Paperplane Therapeutics based?

Paperplane Therapeutics is headquartered in Granby, Canada, in the North America region.

How does Paperplane Therapeutics make money?

Three revenue lines are on record. Healthcare Licensing Model is the primary driver. The others are dental Practice Subscriptions and hardware Sales.

Who are Paperplane Therapeutics's main competitors?

Direct peers on record are AppliedVR, Smileyscope, XRHealth and BehaVR. Broad incumbents are Penumbra (REAL Immersive System), MindMaze, Headspace Health and Calm Health. Emerging players are Psious and Limbic (previously Headspace for Health / mental-health DTx).

Does Paperplane Therapeutics have an API?

No public API is recorded for Paperplane Therapeutics.

What industry is Paperplane Therapeutics in?

Paperplane Therapeutics's product category is Virtual Reality Therapeutics Software. Its primary akta.pro industry code is HLACANAL, Pediatrics & Adolescent Therapeutics (Digital), with a secondary code of HLACANAH, Therapeutic Companion Apps (Drug-Device-Digital Combination). Its NAICS code is 339114 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Paperplane Therapeutics: $1.5 Million Secured For Transforming Pain ManagementPaperplane Therapeutics closed a $1.5 million funding round led by Glen Ventures with support from Quebec's Investissement Québec. The company will use the funds to expand its virtual reality pain and anxiety management solutions in North America and pursue a European expansion via a partnership with HypnoVR.BetaKitPaperplane Therapeutics raises $1.5 million to ease anxious patients with VR gamingMontréal-based Paperplane Therapeutics has secured $1.5 million CAD in seed funding led by Glen Ventures to expand its therapeutic virtual reality gaming platform for managing patient pain and anxiety. The company plans to utilize this capital to broaden its reach across North America and Europe through a strategic partnership with French firm HypnoVR. This expansion builds on existing partnerships with major healthcare institutions such as Cedars-Sinai and Mayo Clinic.WHNT.comPaperplane Therapeutics Raises $1.5M to Transform Anxiety and Pain Management with Medical Virtual RealityPaperplane Therapeutics raised $1.5M in funding led by Glen Ventures with Quebec government support. The company will use the funds to expand its virtual reality pain and anxiety management in dentistry and support a European expansion via a partnership with HypnoVR.Dental Products ReportDream Dental Is a New Interactive Virtual Reality Platform for Dental Patients from Paperplane TherapeuticsPaperplane Therapeutics has launched Dream Dental, an interactive virtual reality platform designed to help dental patients remain calm and still during procedures. The system uses VR headsets with specific motion-tracking technology that narrows the virtual environment if the patient moves, encouraging them to stay still while clinicians control the experience via iPad.GlobeNewswireThe Fondation de l’Hôtel-Dieu d’Alma, Paperplane Therapeutics and TELUS leverage virtual reality to decrease anxiety in hospital settingsThe Alma Hospital Foundation launched a virtual reality anxiety-management project with Paperplane Therapeutics and TELUS, using immersive headsets to reduce patient stress before treatments. A study showed 80% of patients felt less anxious, and the project may expand to oncology and other departments.